The Weekly Investment Analysts’ Ratings Changes for Cascadian Therapeutics (CASC)

The Weekly Investment Analysts’ Ratings Changes for Cascadian Therapeutics (CASC)

Several brokerages have updated their recommendations and price targets on shares of Cascadian Therapeutics (NASDAQ: CASC) in the last few weeks:

Cascadian Therapeutics Inc. (NASDAQ:CASC) opened at 1.02 on Monday. Cascadian Therapeutics Inc. has a 1-year low of $0.82 and a 1-year high of $3.75. The firm has a 50-day moving average price of $1.15 and a 200-day moving average price of $1.16. The firm’s market capitalization is $138.02 million.

Related posts

Leave a Comment